Parkinson’s disease treatment with shockwaves

Código QR

Parkinson’s disease treatment with shockwaves

Guardado en:

Detalles Bibliográficos
Autores principales:	Pavel Novak, Henning Lohse-Busch
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/d567000cc1b4483c9326cbcbec6b3165
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Shockwave modulation, stimulation and regeneration of the brain: a review
por: Pavel Novak
Publicado: (2021)

Spinal cord stimulation treatment for freezing of gait in Parkinson's disease: A case report
por: Peng-Bo Zhou, et al.
Publicado: (2022)

A computational basal ganglia-thalamocortical circuitry model for Parkinson’s disease
por: Ivan Carmona Tortolero, et al.
Publicado: (2021)

Disparities surrounding DBS surgery for Parkinson’s disease and essential tremor in Hawaii
por: Gina Watanabe, et al.
Publicado: (2021)

'The clue is in the origin Watson!' – the tale of a DBS surgery for misdiagnosed Parkinson's Disease
por: Hargunbir Singh, et al.
Publicado: (2021)

Amplitude and frequency modulation of subthalamic beta oscillations as biomarkers of the dopaminergic state in Parkinson’s disease
por: Alberto Averna, et al.
Publicado: (2021)

What happens in vagus doesn't stay in vagus....a stimulating way to treat parkinson's disease
por: Heather Boger, et al.
Publicado: (2021)

Galvanic Vestibular Stimulation effects on LSTM-based EEG neuro-markers of Motor Vigor in Parkinson's Disease
por: Maryam S. Mirian, et al.
Publicado: (2021)

The effects of long-term application of transcranial direct current stimulation on transfer of motor learning in Parkinson’s disease
por: Milan Pantovic, et al.
Publicado: (2021)

Different effects of dopaminergic medications on subthalamic beta bursts and non-oscillatory fractal components in parkinson’s disease: a longitudinal study
por: Ghazaleh Darmani, et al.
Publicado: (2021)

Rasagiline in treatment of Parkinson&rsquo;s disease
por: Lakshmi Nayak, et al.
Publicado: (2008)

Current approaches to the treatment of Parkinson&rsquo;s disease
por: Joseph Jankovic, et al.
Publicado: (2008)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
por: Holly A Shill, et al.
Publicado: (2008)

Repetitive transcranial magnetic stimulation (rTMS) in the treatment of bipolar depression
por: Tomáš Novák, et al.
Publicado: (2021)

The augmentation of cognitive training with tDCS in the treatment of cognitive deficit in schizophrenia
por: Veronika Voráčková, et al.
Publicado: (2021)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
por: Jennifer L Reingold, et al.
Publicado: (2007)

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease
por: Radu Constantinescu
Publicado: (2008)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas P, et al.
Publicado: (2013)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
por: Emma L Lane, et al.
Publicado: (2008)

Depression in Parkinson&rsquo;s disease: Health risks, etiology, and treatment options
por: Pasquale G Frisina, et al.
Publicado: (2008)

Application of repetitive transcranial magnetic stimulation treatment benefits language performance in Alzheimer’s disease: a case study
por: Georgia Roumpea, et al.
Publicado: (2021)

Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt
por: El-Tallawy HN, et al.
Publicado: (2013)

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson&rsquo;s disease: implications for patients
por: Antonini A, et al.
Publicado: (2011)

Review: management of Parkinson&#39;s disease
por: Pedrosa DJ, et al.
Publicado: (2013)

Parkinson’s disease-associated melanin steal
por: Hinz M, et al.
Publicado: (2014)

Sleep disorders in Parkinson&rsquo;s disease
por: Israt Jahan, et al.
Publicado: (2009)

Daytime sleepiness in elderly Parkinson&rsquo;s disease patients and treatment with the psychostimulant modafinil: A preliminary study
por: Johan L&ouml;kk
Publicado: (2010)

Conditional disruption of AMP kinase in dopaminergic neurons promotes Parkinson's disease-associated phenotypes in vivo
por: Liting Hang, et al.
Publicado: (2021)

Relationship between dose and duration of treatment response in severely treatment-resistant depression patients treated with accelerated intermittent theta bust stimulation
por: Ian Kratter, et al.
Publicado: (2021)

Parkinson's disease managing reversible neurodegeneration [Corrigendum]
por: Hinz M, et al.
Publicado: (2016)

Developing and evaluating treatments for the challenges of autism and related neurodevelopmental disabilities
por: Leonard Abbeduto, et al.
Publicado: (2021)

Patient-specific network modeling to personalize neurostimulation treatment in depression
por: Zelma Kiss
Publicado: (2021)

Use of the Virtual Brain to target networks in treatment resistant depression
por: Sora An, et al.
Publicado: (2021)

COVID-encephalopathy treatment with transcranial near infrared laser stimulation
por: Li-Da Huang, et al.
Publicado: (2021)

Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
por: Combs BL, et al.
Publicado: (2017)

Research challenges in chronic diseases: Difficult to treat depression
por: A. John Rush, et al.
Publicado: (2021)

TDCS neuromodulation to enhance cognitive and proprioceptive treatment of Burning Mouth Syndrome
por: Francisco José Sánchez Cuesta, et al.
Publicado: (2021)

fMRI-guided methods for rTMS targeting and treatment prediction
por: Conor Liston
Publicado: (2021)

Covid effects on clinical outcomes of TMS treatment: a naturalistic study
por: A.IREM SONMEZ, et al.
Publicado: (2021)

Prolonged intermittent theta burst stimulation in the treatment of major depressive disorder
por: Clémence Noiseux, et al.
Publicado: (2021)